Tandem Diabetes Care Inc (TNDM)
30.81
+0.07
(+0.23%)
USD |
NASDAQ |
Nov 22, 16:00
30.90
+0.09
(+0.29%)
After-Hours: 20:00
Tandem Diabetes Care Free Cash Flow: -37.35M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -37.35M |
| June 30, 2024 | -64.24M |
| March 31, 2024 | -66.71M |
| December 31, 2023 | -83.41M |
| September 30, 2023 | -48.52M |
| June 30, 2023 | -41.28M |
| March 31, 2023 | -32.80M |
| December 31, 2022 | 7.512M |
| September 30, 2022 | 21.21M |
| June 30, 2022 | 50.36M |
| March 31, 2022 | 73.84M |
| December 31, 2021 | 87.85M |
| September 30, 2021 | 85.10M |
| June 30, 2021 | 61.77M |
| March 31, 2021 | 44.93M |
| December 31, 2020 | -7.625M |
| September 30, 2020 | -6.072M |
| June 30, 2020 | 4.601M |
| March 31, 2020 | 0.50M |
| December 31, 2019 | 22.36M |
| September 30, 2019 | 22.92M |
| June 30, 2019 | 0.052M |
| Date | Value |
|---|---|
| March 31, 2019 | -4.051M |
| December 31, 2018 | -11.30M |
| September 30, 2018 | -37.61M |
| June 30, 2018 | -52.40M |
| March 31, 2018 | -61.18M |
| December 31, 2017 | -71.85M |
| September 30, 2017 | -75.12M |
| June 30, 2017 | -76.15M |
| March 31, 2017 | -75.67M |
| December 31, 2016 | -70.10M |
| September 30, 2016 | -65.69M |
| June 30, 2016 | -61.48M |
| March 31, 2016 | -66.40M |
| December 31, 2015 | -64.60M |
| September 30, 2015 | -66.97M |
| June 30, 2015 | -65.44M |
| March 31, 2015 | -63.30M |
| December 31, 2014 | -65.96M |
| September 30, 2014 | -65.98M |
| June 30, 2014 | -65.00M |
| March 31, 2014 | -62.31M |
| December 31, 2013 | -53.77M |
Free Cash Flow Range, Past 5 Years
-83.41M
Minimum
Dec 2023
87.85M
Maximum
Dec 2021
3.602M
Average
2.550M
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp | 1.892B |
| Masimo Corp | 149.60M |
| RxSight Inc | -27.17M |
| Perspective Therapeutics Inc | -40.58M |
| Xtant Medical Holdings Inc | -17.28M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 26.78M |
| Cash from Investing (Quarterly) | -19.90M |
| Cash from Financing (Quarterly) | -4.519M |
| Free Cash Flow Per Share (Quarterly) | 0.3287 |
| Free Cash Flow to Equity (Quarterly) | 21.04M |
| Free Cash Flow to Firm (Quarterly) | 21.54M |
| Free Cash Flow Yield | -1.86% |